Ran X, Wuu J, Qin ZS, McDermott MP, Cooper-Knock J, Li Y, Granit V, Grignon AL, Lin E, Fernandez MC, Colato D, Carberry N, Lill CM, Piazza P, Malaspina A, Benatar M. Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS. Nature Medicine, 2026. Online ahead of print. https://www.nature.com/articles/s41591-026-04528-x. [PubMed link: 42509371]
Recent Posts
- Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention
- Webinar: Update on the ATLAS Trial for Asymptomatic SOD1 Gene Carriers
- July 26, 2026: Miami Marlins Game
- Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
- The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
Recent Comments